The critical role of the GPCRs–cAMP signaling pathway in the pathophysiology of MDs has been further highlighted by the identification of disease-causing variants in PDE10A (OMIM 610652) and PDE2A (OMIM 602658). Here, PDE2A is linked to myelodysplastic syndrome.